» Articles » PMID: 35677434

Resveratrol Attenuates High Glucose-Induced Osteoblast Dysfunction AKT/GSK3β/FYN-Mediated NRF2 Activation

Overview
Journal Front Pharmacol
Date 2022 Jun 9
PMID 35677434
Authors
Affiliations
Soon will be listed here.
Abstract

Osteoblast dysfunction, induced by high glucose (HG), negatively impacts bone homeostasis and contributes to the pathology of diabetic osteoporosis (DOP). One of the most widely recognized mechanisms for osteoblast dysfunction is oxidative stress. Resveratrol (RES) is a bioactive antioxidant compound to combat oxidative damage. However, its role in the protection of HG-induced osteoblast dysfunction has not been clarified. Therefore, our study aimed to explore potential regulatory mechanisms of RES for attenuating HG-induced osteoblast dysfunction. Our results showed that osteoblast dysfunction under HG condition was significantly ameliorated by RES the activation of nuclear factor erythroid 2-related factor (NRF2) to suppress oxidative stress. Furthermore, using -shRNA and wortmannin, we identified that activation of NRF2 RES was regulated by the AKT/glycogen synthase kinase 3β (GSK3β)/FYN axis.

Citing Articles

CLDN6 triggers NRF2-mediated ferroptosis through recruiting DLG1/PBK complex in breast cancer.

Qi D, Lu Y, Qu H, Dong Y, Jin Q, Sun M Cell Death Dis. 2025; 16(1):122.

PMID: 39984471 PMC: 11845765. DOI: 10.1038/s41419-025-07448-9.


Role of oxidative stress in impaired type II diabetic bone repair: scope for antioxidant therapy intervention?.

Li P, Alenazi K, Dally J, Woods E, Waddington R, Moseley R Front Dent Med. 2025; 5:1464009.

PMID: 39917650 PMC: 11797775. DOI: 10.3389/fdmed.2024.1464009.


miRNA-seq analysis of high glucose induced osteoblasts provides insight into the mechanism underlying diabetic osteoporosis.

Zhang Y, Li M, Lou P, Zhang M, Shou D, Tong P Sci Rep. 2024; 14(1):13441.

PMID: 38862780 PMC: 11166950. DOI: 10.1038/s41598-024-64391-z.


-Stilbenes: General Chemical and Biological Aspects, Potential Pharmacological Activity Based on the Nrf2 Pathway.

Mendonca E, Xavier J, Fragoso M, Silva M, Escodro P, Oliveira A Pharmaceuticals (Basel). 2024; 17(2).

PMID: 38399446 PMC: 10891666. DOI: 10.3390/ph17020232.


Catalpol Promotes Osseointegration of Titanium Implants under Conditions of Type 2 Diabetes via AKT/GSK3β/FYN Pathway-Mediated NRF2 Activation.

Zhang Y, Zhang J, Sun B, Ma L, Ma Y ACS Omega. 2024; 9(5):5761-5771.

PMID: 38343941 PMC: 10851378. DOI: 10.1021/acsomega.3c08518.


References
1.
Lin D, Dai F, Sun L, Zhou B . Toward an understanding of the role of a catechol moiety in cancer chemoprevention: The case of copper- and o-quinone-dependent Nrf2 activation by a catechol-type resveratrol analog. Mol Nutr Food Res. 2015; 59(12):2395-406. DOI: 10.1002/mnfr.201500297. View

2.
Khosla S, Hofbauer L . Osteoporosis treatment: recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017; 5(11):898-907. PMC: 5798872. DOI: 10.1016/S2213-8587(17)30188-2. View

3.
Fatokun A, Stone T, Smith R . Hydrogen peroxide-induced oxidative stress in MC3T3-E1 cells: The effects of glutamate and protection by purines. Bone. 2006; 39(3):542-51. DOI: 10.1016/j.bone.2006.02.062. View

4.
Wang N, He J, Pan C, Wang J, Ma M, Shi X . Resveratrol Activates Autophagy via the AKT/mTOR Signaling Pathway to Improve Cognitive Dysfunction in Rats With Chronic Cerebral Hypoperfusion. Front Neurosci. 2019; 13:859. PMC: 6710371. DOI: 10.3389/fnins.2019.00859. View

5.
Han D, Gu X, Gao J, Wang Z, Liu G, Barkema H . Chlorogenic acid promotes the Nrf2/HO-1 anti-oxidative pathway by activating p21 to resist dexamethasone-induced apoptosis in osteoblastic cells. Free Radic Biol Med. 2019; 137:1-12. DOI: 10.1016/j.freeradbiomed.2019.04.014. View